{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:49:50Z","timestamp":1757623790250,"version":"3.44.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14675-y","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:01:43Z","timestamp":1755694903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Three-year survival outcomes following radical hysterectomy in early-stage cervical carcinoma: A study at Bugando medical centre, Mwanza, Tanzania"],"prefix":"10.1186","volume":"25","author":[{"given":"Alfred","family":"Mushumbusi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey","family":"Kaizilege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elieza","family":"Chibwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Ottoman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kiritta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dismas","family":"Matovelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgar","family":"Ndaboine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benson","family":"Kidenya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"14675_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"14675_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.25259\/CMAS_03_02_2021","volume":"19","author":"S Pimple","year":"2022","unstructured":"Pimple S, Mishra G. Cancer cervix: epidemiology and disease burden. CytoJournal. 2022;19:21.","journal-title":"CytoJournal"},{"key":"14675_CR3","doi-asserted-by":"publisher","first-page":"e064321","DOI":"10.1136\/bmjopen-2022-064321","volume":"12","author":"A Mremi","year":"2022","unstructured":"Mremi A, Mchome B, Mlay J, Schledermann D, Blaak\u00e6r J, Rasch V. Performance of HPV testing, pap smear and VIA in women attending cervical cancer screening in Kilimanjaro region, Northern tanzania: a cross-sectional study nested in a cohort. BMJ Open. 2022;12:e064321.","journal-title":"BMJ Open"},{"key":"14675_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/cancers14030575","volume":"14","author":"YM Guimar\u00e3es","year":"2022","unstructured":"Guimar\u00e3es YM, Godoy LR, Longatto-Filho A, Reis R. Management of early-stage cervical cancer: a literature review. Cancers. 2022;14:575.","journal-title":"Cancers"},{"key":"14675_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-023-11764-8","volume":"24","author":"GK Kaizilege","year":"2024","unstructured":"Kaizilege GK, Ndaboine E, Chuma C, et al. Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at Bugando medical centre. Mwanza BMC cancer. 2024;24:1\u20137.","journal-title":"Mwanza BMC cancer"},{"key":"14675_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-5-406","volume":"5","author":"D Matovelo","year":"2012","unstructured":"Matovelo D, Magoma M, Rambau P, Massinde A, Masalu N. HIV serostatus and tumor differentiation among patients with cervical cancer at Bugando medical centre. BMC Res Notes. 2012;5:1\u20138.","journal-title":"BMC Res Notes"},{"key":"14675_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ijgo.13865","volume":"155","author":"N Bhatla","year":"2021","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynecol Obstet. 2021;155:28\u201344.","journal-title":"Int J Gynecol Obstet"},{"key":"14675_CR8","doi-asserted-by":"publisher","first-page":"823064","DOI":"10.3389\/fonc.2022.823064","volume":"12","author":"Y-f Zhang","year":"2022","unstructured":"Zhang Y-f, Fan Y, Zhang P, Ruan J-y, Mu Y, Li J-k. Cervical cancer recurrence and patient survival after radical hysterectomy followed by either adjuvant chemotherapy or adjuvant radiotherapy with optional concurrent chemotherapy: A systematic review and meta-analysis. Front Oncol. 2022;12:823064.","journal-title":"Front Oncol"},{"key":"14675_CR9","doi-asserted-by":"crossref","unstructured":"Rodriguez J, Viveros-Carre\u00f1o D, Pareja R. Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update? Int J Gynecologic Cancer 2022; 32.","DOI":"10.1136\/ijgc-2022-003735"},{"key":"14675_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix Uteri. Int J Gynecol Obstet. 2018;143:22\u201336.","journal-title":"Int J Gynecol Obstet"},{"key":"14675_CR11","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.52768\/2766-7820\/2206","volume":"3","author":"E Ndaboine","year":"2022","unstructured":"Ndaboine E, Celestine E, Matovelo D, et al. Outcomes of patients undergoing radical hysterectomy for early-stage cervical cancer at Bugando medical centre, Mwanza\u2013Tanzania. J Clin Images Med Case Rep. 2022;3:2206.","journal-title":"J Clin Images Med Case Rep"},{"key":"14675_CR12","doi-asserted-by":"crossref","unstructured":"K\u00f6hler C, Hertel H, Herrmann J et al. Laparoscopic radical hysterectomy with transvaginal closure of vaginal cuff\u2013a multicenter analysis. Int J Gynecologic Cancer 2019; 29.","DOI":"10.1136\/ijgc-2019-000388"},{"key":"14675_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.20527\/jbk.v17i1.10248","volume":"17","author":"S Teguh","year":"2021","unstructured":"Teguh S, Hariadi H, Armanza F, Sabaruddin H. Survival rate analysis of early stage cervical Cancer patients after radical hysterectomy in Ulin Banjarmasin general hospital, Indonesia. Berkala Kedokteran. 2021;17:39\u201346.","journal-title":"Berkala Kedokteran"},{"key":"14675_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jjco\/hyab047","volume":"51","author":"G Zhang","year":"2021","unstructured":"Zhang G, He F, Miao L, Wu H, Zhang Y, Fu C. Post-operative small pelvic intensity-modulated radiation therapy for early-stage cervical cancer with intermediate-risk factors: efficacy and toxicity. Jpn J Clin Oncol. 2021;51:905\u201310.","journal-title":"Jpn J Clin Oncol"},{"key":"14675_CR15","doi-asserted-by":"crossref","unstructured":"Nie J, Wu Q, Yan A, Wu Z. Impact of different therapies on the survival of patients with stage I\u2013IIA cervical cancer with intermediate risk factors. Annals Translational Med 2021; 9.","DOI":"10.21037\/atm-20-7679"},{"key":"14675_CR16","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1148\/rg.326125519","volume":"32","author":"SJ Freeman","year":"2012","unstructured":"Freeman SJ, Aly AM, Kataoka MY, Addley HC, Reinhold C, Sala E. The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics. 2012;32:1805\u201327.","journal-title":"Radiographics"},{"key":"14675_CR17","doi-asserted-by":"publisher","first-page":"532748","DOI":"10.3389\/fonc.2020.532748","volume":"10","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li J, Gu H, Tu H, Liu G, Liu J. Clear cell adenocarcinoma of uterine cervix: A single institution retrospective experience. Front Oncol. 2020;10:532748.","journal-title":"Front Oncol"},{"key":"14675_CR18","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/cancers14133140","volume":"14","author":"ML Ten Eikelder","year":"2022","unstructured":"Ten Eikelder ML, Hinten F, Smits A, et al. Does the new FIGO 2018 staging system allow better prognostic differentiation in early stage cervical cancer? A Dutch nationwide cohort study. Cancers. 2022;14:3140.","journal-title":"Cancers"},{"key":"14675_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/gyno.1999.5387","volume":"73","author":"A Sedlis","year":"1999","unstructured":"Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A gynecologic oncology group study. Gynecol Oncol. 1999;73:177\u201383.","journal-title":"Gynecol Oncol"},{"key":"14675_CR20","doi-asserted-by":"publisher","first-page":"e54","DOI":"10.3802\/jgo.2020.31.e54","volume":"31","author":"D Cibula","year":"2020","unstructured":"Cibula D. Management of patients with intermediate-risk early stage cervical cancer. J Gynecologic Oncol. 2020;31:e54.","journal-title":"J Gynecologic Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14675-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14675-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:06:16Z","timestamp":1757408776000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14675-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14675"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14675-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"type":"electronic","value":"1471-2407"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study strictly adhered to relevant guidelines and regulations, ensuring ethical standards were upheld throughout data extraction and analysis, with measures taken to ensure data anonymization. Ethical approval was obtained from the Institutional Review Board, the Joint Ethical, Research, and Publication Committee of the Catholic University of Health and Allied Sciences and Bugando Medical Centre (CUHAS\/BMC), under reference CREC 717\/2023. The IRB reviewed the study\u2019s legal and ethical considerations and granted a waiver for participant consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"1343"}}